Ads
related to: pfe- MarketWatch.com
MarketWatch Provides The Latest
Stock Market & Business News.
- Economy & Politics
Learn About The Impact Of Current
Events On The Economy Today.
- Personal Finance
Read The Latest Stories On What The
Financial News Of The Day Means.
- Investing
See The News, Analysis And
Advice On Investing Here.
- MarketWatch.com
Search results
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 14 hours agoA month has gone by since the last earnings report for Pfizer (PFE). Shares have added about 1.8% in...
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 11 hours agoOn Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial...
How To Earn $500 A Month From Pfizer Stock
Benzinga via Yahoo Finance· 15 hours agoShares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 14 hours agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year —...
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
Motley Fool via Yahoo Finance· 22 hours agoFool.com contributor Parkev Tatevosian reviews Pfizer (NYSE: PFE) stock for passive income...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 1 day agoLoading... Loading... Investors with a lot of money to spend have taken a bearish stance on Pfizer PFE . And retail traders should know. We noticed this today when the positions ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 7 hours agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Pfizer Stock: Chart Indicates a Long-Term Bottom , But Is the Dividend Safe? | Investing.com
Investing.com· 5 days agoA couple of weeks ago, this blog’s technician (@GarySMorrow found on X) shot me a message, noting...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 3 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca...
